Meike Vogler

4.1k total citations · 1 hit paper
59 papers, 2.9k citations indexed

About

Meike Vogler is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Meike Vogler has authored 59 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 21 papers in Oncology and 13 papers in Immunology. Recurrent topics in Meike Vogler's work include Cell death mechanisms and regulation (30 papers), RNA Interference and Gene Delivery (12 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Meike Vogler is often cited by papers focused on Cell death mechanisms and regulation (30 papers), RNA Interference and Gene Delivery (12 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Meike Vogler collaborates with scholars based in Germany, United Kingdom and United States. Meike Vogler's co-authors include Martin J.S. Dyer, Gerald M. Cohen, David Dinsdale, Simone Fulda, Klaus‐Michael Debatin, Michael Butterworth, Xiaoming Sun, Renata Walewska, Aneela Majid and Felicitas Genze and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Meike Vogler

57 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy

2025 56 citations Meike Vogler, Yannick Braun et al. profile →

Peers

Meike Vogler

ONCOL

IMMUN

GENET

Stephen K. Tahir United States

Cassandra J. Vandenberg Australia

Alexandre Arcaro Switzerland

Manfred Jücker Germany

Gaël Roué Spain

Miriam Erlacher Germany

Jianbiao Zhou Singapore

Arnaud Jacquel France

Paul Nimmer United States

Carlo M. Croce United States

Stephen K. Tahir United States

Meike Vogler

2.4k ×1.1

980 ×1.3

ONCOL

391 ×0.7

IMMUN

344 ×0.9

GENET

247 ×0.7

Citations per year, relative to Meike Vogler Meike Vogler (= 1×) peers Stephen K. Tahir

Countries citing papers authored by Meike Vogler

Since Specialization

Citations

This map shows the geographic impact of Meike Vogler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meike Vogler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meike Vogler more than expected).

Fields of papers citing papers by Meike Vogler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meike Vogler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meike Vogler. The network helps show where Meike Vogler may publish in the future.

Co-authorship network of co-authors of Meike Vogler

This figure shows the co-authorship network connecting the top 25 collaborators of Meike Vogler. A scholar is included among the top collaborators of Meike Vogler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meike Vogler. Meike Vogler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bexte, Tobias, Stephanie Hehlgans, Florian Rothweiler, et al.. (2025). Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy. Journal for ImmunoTherapy of Cancer. 13(7). e011330–e011330.

Nguyen, Duy, Sara Najafi, Norman Mack, et al.. (2024). Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours. British Journal of Cancer. 131(4). 763–777. 1 indexed citations

Vogler, Meike, et al.. (2024). Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC. Cell Communication and Signaling. 22(1). 415–415. 2 indexed citations

Theilen, Till‐Martin, et al.. (2024). Fluorescence confocal microscopy for evaluation of fresh surgical specimens and consecutive tumor cell isolation in rare pediatric tumors. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(3). 585–593. 2 indexed citations

Smith, Victoria M., et al.. (2024). Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines. Cell Death and Disease. 15(4). 266–266. 2 indexed citations

Bukur, Thomas, et al.. (2023). Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids. Cells. 12(6). 906–906.

Demes, Melanie, Yannick Braun, Elise Gradhand, et al.. (2023). Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastoma. British Journal of Cancer. 129(10). 1667–1678. 9 indexed citations

Bankov, Katrin, Nina I. Becker, Elise Gradhand, et al.. (2022). Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy. Cell Death Discovery. 8(1). 11–11. 19 indexed citations

Vogler, Meike, et al.. (2021). Unleashing the power of NK cells in anticancer immunotherapy. Journal of Molecular Medicine. 100(3). 337–349. 20 indexed citations

10.

Vogler, Meike, et al.. (2020). A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma. British Journal of Cancer. 122(10). 1544–1551. 25 indexed citations

11.

Vervloessem, Tamara, Binu K. Sasi, Spyridoula Karamanou, et al.. (2020). BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models. Cell Death and Disease. 11(9). 769–769. 20 indexed citations

12.

Hugle, Manuela, et al.. (2018). NRAS -Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3K α. Cancer Research. 78(8). 2000–2013. 14 indexed citations

13.

Vogler, Meike, Harriet S. Walter, Sandrine Jayne, et al.. (2018). Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines. Cancers. 10(4). 127–127. 24 indexed citations

14.

Heinicke, Ulrike, et al.. (2018). BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis. Oncogene. 37(39). 5325–5339. 25 indexed citations

15.

Vogler, Meike. (2014). Targeting BCL2-Proteins for the Treatment of Solid Tumours. SHILAP Revista de lepidopterología. 2014. 1–14. 89 indexed citations

16.

Vogler, Meike, Silviya D. Furdas, Manfred Jung, et al.. (2010). Diminished Sensitivity of Chronic Lymphocytic Leukemia Cells to ABT-737 and ABT-263 Due to Albumin Binding in Blood. Clinical Cancer Research. 16(16). 4217–4225. 42 indexed citations

17.

Vogler, Meike, Henning Walczak, Dominic Stadel, et al.. (2009). Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic Carcinoma. Cancer Research. 69(6). 2425–2434. 121 indexed citations

18.

Vogler, Meike, Henning Walczak, Dominic Stadel, et al.. (2008). Targeting XIAP Bypasses Bcl-2–Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo. Cancer Research. 68(19). 7956–7965. 135 indexed citations

19.

Vogler, Meike, Michael Butterworth, Aneela Majid, et al.. (2008). Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood. 113(18). 4403–4413. 264 indexed citations

20.

Vogler, Meike, et al.. (2005). Sensitization for γ-Irradiation–Induced Apoptosis by Second Mitochondria-Derived Activator of Caspase. Cancer Research. 65(22). 10502–10513. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact